Prenatal diagnosis of pontocerebellar hypoplasia with postnatal follow-up.


Journal

Prenatal diagnosis
ISSN: 1097-0223
Titre abrégé: Prenat Diagn
Pays: England
ID NLM: 8106540

Informations de publication

Date de publication:
02 Jan 2024
Historique:
revised: 25 11 2023
received: 02 08 2023
accepted: 04 12 2023
medline: 2 1 2024
pubmed: 2 1 2024
entrez: 2 1 2024
Statut: aheadofprint

Résumé

To describe the MR features enabling prenatal diagnosis of pontocerebellar hypoplasia (PCH). This was a retrospective single monocentre study. The inclusion criteria were decreased cerebellar biometry on dedicated neurosonography and available fetal Magnetic Resonance Imaging (MRI) with PCH diagnosis later confirmed either genetically or clinically on post-natal MRI or by autopsy. The exclusion criteria were non-available MRI and sonographic features suggestive of a known genetic or other pathologic diagnosis. The collected data were biometric or morphological imaging parameters, clinical outcome, termination of pregnancy (TOP), pathological findings and genetic analysis (karyotyping, chromosomal microarray, DNA sequencing targeted or exome). PCH was classified as classic, non-classic, chromosomal, or unknown type. Forty-two fetuses were diagnosed with PCH, of which 27 were referred for decreased transverse cerebellar diameter at screening ultrasound. Neurosonography and fetal MRI were performed at a mean gestational age of 29 + 4 and 31 + 0 weeks, respectively. Termination of pregnancy occurred. Pregnancy was terminated in 24 cases. Neuropathological examination confirmed the diagnosis in 24 cases and genetic testing identified abnormalities in 29 cases (28 families, 14 chromosomal anomaly). Classic PCH is associated with pontine atrophy and small MR measurements decreasing with advancing gestation. This is the first large series of prenatally diagnosed PCHs. Our study shows the essential contribution of fetal MRI to the prenatal diagnosis of PCH. Classic PCHs are particularly severe and are associated with certain MR features.

Identifiants

pubmed: 38165124
doi: 10.1002/pd.6495
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 The Authors. Prenatal Diagnosis published by John Wiley & Sons Ltd.

Références

Barth PG. Pontocerebellar hypoplasias. An overview of a group of inherited neurodegenerative disorders with fetal onset. Brain Dev. 1993;15(6):411-422. https://doi.org/10.1016/0387-7604(93)90080-r
Rusch CT, Bolsterli BK, Kottke R, Steinfeld R, Boltshauser E. Pontocerebellar hypoplasia: a pattern recognition approach. Cerebellum. 2020;19(4):569-582. https://doi.org/10.1007/s12311-020-01135-5
van Dijk T, Baas F, Barth PG, Poll-The BT. What's new in pontocerebellar hypoplasia? An update on genes and subtypes. Orphanet J Rare Dis. 2018;13(1):92. https://doi.org/10.1186/s13023-018-0826-2
Namavar Y, Barth PG, Poll-The BT, Baas F. Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia. Orphanet J Rare Dis. 2011;6(1):50. https://doi.org/10.1186/1750-1172-6-50
Steinlin M, Klein A, Haas-Lude K, et al. Pontocerebellar hypoplasia type 2: variability in clinical and imaging findings. Eur J Paediatr Neurol. 2007;11(3):146-152. https://doi.org/10.1016/j.ejpn.2006.11.012
Poretti A, Boltshauser Edoherty D. Cerebellar hypoplasia: differential diagnosis and diagnostic approach. Am J Med Genet C Semin Med Genet. 2014;166C(2):211-226. https://doi.org/10.1002/ajmg.c.31398
Coolen M, Altin N, Rajamani K, et al. Recessive PRDM13 mutations cause fatal perinatal brainstem dysfunction with cerebellar hypoplasia and disrupt Purkinje cell differentiation. Am J Hum Genet. 2022;109(5):909-927. https://doi.org/10.1016/j.ajhg.2022.03.010
Desai Sdesai T. Prenatal diagnosis of pontocerebellar hypoplasia associated with rare syndromes: expanding the genetic and phenotypic spectrum. Ultrasound Obstet Gynecol. 2021;57(3):498-499. https://doi.org/10.1002/uog.22038
Goasdoue P, Rodriguez D, Moutard ML, Robain O, Lalande G, Adamsbaum C. Pontoneocerebellar hypoplasia: definition of MR features. Pediatr Radiol. 2001;31(9):613-618. https://doi.org/10.1007/s002470100507
Kaul SCS, Chandra S. CASK related Pontocerebellar Hypoplasia: a rare cause of infantile microcephaly (5422). Neurology. 2020;94(15_Suppl):5422. https://doi.org/10.1212/wnl.94.15_supplement.5422
Patel MS, Becker LE, Toi A, Armstrong DL, Chitayat D. Severe, fetal-onset form of olivopontocerebellar hypoplasia in three sibs: PCH type 5? Am J Med Genet. 2006;140(6):594-603. https://doi.org/10.1002/ajmg.a.31095
Tortora M, Spaccini L, Lanna M, et al. TSEN54 gene-related pontocerebellar-hypoplasia and role of prenatal MR imaging: besides the common posterior fossa cystic malformations. Cerebellum. 2022;22(5):1023-1025. https://doi.org/10.1007/s12311-022-01457-6
van Dijk T, Ferdinandusse S, Ruiter JPN, et al. Biallelic loss of function variants in COASY cause prenatal onset pontocerebellar hypoplasia, microcephaly, and arthrogryposis. Eur J Hum Genet. 2018;26(12):1752-1758. https://doi.org/10.1038/s41431-018-0233-0
Chavez MR, Ananth CV, Smulian JC, Vintzileos AM. Fetal transcerebellar diameter measurement for prediction of gestational age at the extremes of fetal growth. J Ultrasound Med. 2007;26(9):1167-1171. quiz 1173-4. https://doi.org/10.7863/jum.2007.26.9.1167
Leibovitz Z, Shkolnik C, Haratz KK, Malinger G, Shapiro I, Lerman-Sagie T. Assessment of fetal midbrain and hindbrain in mid-sagittal cranial plane by three-dimensional multiplanar sonography. Part 1: comparison of new and established nomograms. Ultrasound Obstet Gynecol. 2014;44(5):575-580. https://doi.org/10.1002/uog.13308
Salomon LJ, Duyme M, Crequat J, et al. French fetal biometry: reference equations and comparison with other charts. Ultrasound Obstet Gynecol. 2006;28(2):193-198. https://doi.org/10.1002/uog.2733
Shi Y, Xue Y, Chen C, Lin K, Zhou Z. Association of gestational age with MRI-based biometrics of brain development in fetuses. BMC Med Imag. 2020;20(1):125. https://doi.org/10.1186/s12880-020-00525-9
Tilea B, Alberti C, Adamsbaum C, et al. Cerebral biometry in fetal magnetic resonance imaging: new reference data. Ultrasound Obstet Gynecol. 2009;33(2):173-181. https://doi.org/10.1002/uog.6276
Jandeaux C, Kuchcinski G, Ternynck C, et al. Biometry of the cerebellar vermis and brain stem in children: MR imaging reference data from measurements in 718 children. AJNR Am J Neuroradiol. 2019;40(11):1835-1841. https://doi.org/10.3174/ajnr.A6257
Ellison D. LoveS. Neuropathology. Mosby; 1998.608.
Anderson C, Davies JH, Lamont L, Foulds N. Early pontocerebellar hypoplasia with vanishing testes: a new syndrome? Am J Med Genet. 2011;155A(4):667-672. https://doi.org/10.1002/ajmg.a.33897
Barth PG, Aronica E, de Vries L, et al. Pontocerebellar hypoplasia type 2: a neuropathological update. Acta Neuropathol. 2007;114(4):373-386. https://doi.org/10.1007/s00401-007-0263-0
ten Donkelaar HJ, Lammens M, Wesseling P, Thijssen HO, Renier WO. Development and developmental disorders of the human cerebellum. J Neurol. 2003;250(9):1025-1036. https://doi.org/10.1007/s00415-003-0199-9
Conference nationale de l'echographie obstetricale et f. The French national committee on obstetrical and fetal ultrasound guidelines 2022 (CNEOF). Gynecol Obstet Fertil Senol. 2023; 51(4):221-226. https://doi.org/10.1016/j.gofs.2023.01.006
Ajibola AJ, Netzloff M, Samaraweera R, Omar S. Two cases of pontocerebellar hypoplasia: ethical and prenatal diagnostic dilemma. Am J Perinatol. 2010;27(2):181-187. https://doi.org/10.1055/s-0029-1234030
Graham JM, Jr., Spencer AH, Grinberg I, et al. Molecular and neuroimaging findings in pontocerebellar hypoplasia type 2 (PCH2): is prenatal diagnosis possible? Am J Med Genet. 2010;152A(9):2268-2276. https://doi.org/10.1002/ajmg.a.33579
Ucuncu E, Rajamani K, Wilson MSC, et al. MINPP1 prevents intracellular accumulation of the chelator inositol hexakisphosphate and is mutated in Pontocerebellar Hypoplasia. Nat Commun. 2020;11(1):6087. https://doi.org/10.1038/s41467-020-19919-y
Gafner M, Boltshauser E, D'Abrusco F, et al. Expanding the natural history of CASK-related disorders to the prenatal period. Dev Med Child Neurol. 2022;65(4):544-550. https://doi.org/10.1111/dmcn.15419
Lacalm A, Nadaud B, Massoud M, Putoux A, Gaucherand P, Guibaud L. Prenatal diagnosis of cobblestone lissencephaly associated with Walker-Warburg syndrome based on a specific sonographic pattern. Ultrasound Obstet Gynecol. 2016;47(1):117-122. https://doi.org/10.1002/uog.15735
Hagege R, Haratz KK, Malinger G, et al. Spectrum of brain malformations in fetuses with 'mild' tubulinopathies. Ultrasound Obstet Gynecol. 2022. https://doi.org/10.1002/uog.26140
Blondiaux E, Valence S, Friszer S, et al. Prenatal imaging findings of pontine tegmental cap dysplasia: report of four cases. Fetal Diagn Ther. 2019;45(3):197-204. https://doi.org/10.1159/000475989
Blondiaux E, Garel C. Fetal cerebral imaging - ultrasound vs. MRI: an update. Acta Radiol. 2013;54(9):1046-1054. https://doi.org/10.1258/ar.2012.120428
Accogli S, Addour-Boudrahem N, Srour M. Diagnostic approach to cerebellar hypoplasia. Cerebellum. 2020;20(4):631-658. https://doi.org/10.1007/s12311-020-01224-5
Sanchez-Albisua I, Frolich S, Barth PG, Steinlin M, Krägeloh-Mann I. Natural course of pontocerebellar hypoplasia type 2A. Orphanet J Rare Dis. 2014;9(1):70. https://doi.org/10.1186/1750-1172-9-70
Fischer-Zirnsak B, Segebrecht L, Schubach M, et al. Haploinsufficiency of the notch ligand DLL1 causes variable neurodevelopmental disorders. Am J Hum Genet. 2019;105(3):631-639. https://doi.org/10.1016/j.ajhg.2019.07.002
Baer S, Obringer C, Julia S, et al. Early-onset nucleotide excision repair disorders with neurological impairement: clues for early diagnosis and prognosis counseling. Clin Genet. 2020.
Schob C, Hempel M, Safka Brozkova D, et al. Dominant KPNA3 mutations cause infantile-onset hereditary spastic paraplegia. Ann Neurol. 2021;90(5):738-750. https://doi.org/10.1002/ana.26228

Auteurs

Alienor Jaillard (A)

Department of Radiology, Armand-Trousseau Hospital, APHP, Sorbonne University, Paris, France.

Stéphanie Valence (S)

Department of Pediatric Neurology, Reference Center for Rare Diseases and Intellectual Deficiencies of Rare Causes, Armand-Trousseau Hospital, APHP, Sorbonne University, Paris, France.

Saskia Vande Perre (S)

Department of Radiology, Armand-Trousseau Hospital, APHP, Sorbonne University, Paris, France.

Ferdinand Dhombres (F)

Fetal Medicine Department, Armand-Trousseau Hospital, APHP, Sorbonne University, GRC-26, Paris, France.

Delphine Héron (D)

Department of Genetics, Division of Medical Genetics, Reference Center for Rare Diseases and Intellectual Deficiencies of Rare Causes, La Pitié-Salpêtrière Hospital, APHP, Sorbonne University, Paris, France.

Thierry Billette de Villemeur (T)

Department of Pediatric Neurology, Reference Center for Rare Diseases and Intellectual Deficiencies of Rare Causes, Armand-Trousseau Hospital, APHP, Sorbonne University, Paris, France.

Boris Keren (B)

Department of Genetics, APHP, Sorbonne University, La Pitié-Salpêtrière Hospital, Paris, France.

Alexandra Afenjar (A)

Clinical Genetics Unit, Reference Center for Cerebellar Malformations and Congenital Diseases, Armand-Trousseau Hospital, APHP, Sorbonne University, Paris, France.

Leila Qebibo (L)

Department of Genetics, Pediatric Neurogenetics Laboratory, Reference Center for Cerebellar Malformations and Congenital Diseases, Armand-Trousseau Hospital, APHP, Sorbonne University, Paris, France.

Madeleine Harion (M)

Department of Pediatric Neurology, Reference Center for Rare Diseases and Intellectual Deficiencies of Rare Causes, Armand-Trousseau Hospital, APHP, Sorbonne University, Paris, France.

Geneviève Quenum-Miraillet (G)

Department of Medical Genetics, Armand-Trousseau Hospital, APHP, Sorbonne University, Paris, France.

Diana Rodriguez (D)

Department of Pediatric Neurology, Reference Center for Rare Diseases and Intellectual Deficiencies of Rare Causes, Armand-Trousseau Hospital, APHP, Sorbonne University, Paris, France.

Jean-Marie Jouannic (JM)

Fetal Medicine Department, Armand-Trousseau Hospital, APHP, Sorbonne University, Paris, France.

Lydie Burglen (L)

Department of Genetics, Pediatric Neurogenetics Laboratory, Reference Center for Cerebellar Malformations and Congenital Diseases, Armand-Trousseau Hospital, APHP, Sorbonne University, Paris, France.
Developmental Brain Disorders Laboratory, Imagine Institute, Paris, France.

Catherine Garel (C)

Department of Radiology, Reference Center for Cerebellar Malformations and Congenital Diseases, Armand-Trousseau Hospital, APHP, Sorbonne University, INSERM UMR 1163, Paris, France.

Classifications MeSH